Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › MONROE › ST. FRANCIS URGENT CARE LLC

ST. FRANCIS URGENT CARE LLC

NPI: 1194104513 · MONROE, LA 71201 · Urgent Care Clinic/Center · NPI assigned 05/19/2015

$8.36M
Total Medicaid Paid
206,588
Total Claims
171,372
Beneficiaries
29
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWHITE, TAMARA (VP REVENUE CYCLE SERVICES)
NPI Enumeration Date05/19/2015

Related Entities

Other providers sharing the same authorized official: WHITE, TAMARA

ProviderCityStateTotal Paid
ST JOSEPHS CANDLER URGENT CARE CENTERS LLC SAVANNAH GA $674K
OUR LADY OF THE LAKE PHYSICIAN GROUP LLC BATON ROUGE LA $42K
OUR LADY OF THE LAKE HOSPITAL INC BATON ROUGE LA $31K
OUR LAKE OF THE LAKE HEAD AND NECK CE BATON ROUGE LA $846.74
PREMIER MEDICAL CNTR OF HUMACAO LLC HUMACAO PR $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 16,114 $760K
2019 24,677 $1.09M
2020 28,467 $1.21M
2021 34,016 $1.45M
2022 40,078 $1.43M
2023 31,682 $1.28M
2024 31,554 $1.15M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 35,710 32,999 $2.97M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 24,611 22,552 $1.88M
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 14,023 12,810 $1.28M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 15,555 14,345 $1.28M
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 19,186 15,613 $314K
S9088 Services provided in an urgent care center (list in addition to code for service) 14,471 13,560 $146K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 25,731 11,526 $123K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 7,076 5,441 $114K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 13,579 11,206 $61K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 11,095 9,235 $40K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 408 393 $38K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 560 507 $32K
99051 9,746 8,450 $25K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1,547 1,257 $20K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 262 248 $8K
99215 Prolong outpt/office vis 86 84 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 73 63 $4K
87807 957 821 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,602 4,896 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,562 1,229 $2K
81003 2,803 2,374 $1K
71046 Radiologic examination, chest; 2 views 229 208 $847.74
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 66 64 $536.32
81025 229 199 $107.27
99000 170 149 $3.00
A9150 Non-prescription drugs 900 822 $0.75
J1885 Injection, ketorolac tromethamine, per 15 mg 247 220 $0.44
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 67 64 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 37 37 $0.00